Human CD137/4-1BB/TNFRSF9 ELISA Kit

pg/ml |
O.D. |
Average |
Corrected |
|
0.00 |
0.0659 |
0.0698 |
0.0679 |
|
15.63 |
0.1978 |
0.2148 |
0.2063 |
0.1385 |
31.25 |
0.3346 |
0.3512 |
0.3429 |
0.2751 |
62.50 |
0.5916 |
0.6533 |
0.6225 |
0.5546 |
125.00 |
1.1130 |
1.1470 |
1.1300 |
1.0622 |
250.00 |
1.8960 |
1.9670 |
1.9315 |
1.8637 |
500.00 |
3.2850 |
3.4530 |
3.3690 |
3.3012 |
1000.00 |
4.3356 |
4.3766 |
4.3561 |
4.2883 |
Intra-assay Precision |
|
Inter-assay Precision |
|||||
Sample Number |
S1 |
S2 |
S3 |
S1 |
S2 |
S3 |
|
22 |
22 |
22 |
6 |
6 |
6 |
||
Average(pg/ml) |
25.6 |
117.0 |
352.9 |
22.8 |
110.2 |
319.1 |
|
Standard deviation |
1.4 |
3.5 |
10.2 |
1.1 |
2.3 |
12.4 |
|
Coefficient of variation(%) |
5.3 |
3.0 |
2.9 |
4.7 |
2.1 |
3.9 |
- Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
- Inter-assay Precision (Precision between assays)Three samples of known concentration were tested six times on one plate to assess intra-assay precision.
The spike recovery was evaluated by spiking 3 levels of human CD137/4-1BB/TNFRSF9 into health human serum sample. The un-spiked serum was used as blank in this experiment.
The recovery ranged from 86% to 116% with an overall mean recovery of 103%.
Sample Matrix |
Sample Evaluated |
Range (Pg/ml) |
Detectable % |
Mean of Detectable (Pg/ml) |
Serum |
30 |
20.14-49.28 |
100 |
32.58 |
Serum/Plasma - Thirty samples from apparently healthy volunteers were evaluated for the presence of CD137/4-1BB/TNFRSF9 in this assay.No medical histories were available for the donors.
